-
PET-CT是将PET和CT两个设备有机地结合在一起, 使PET与CT优势互补, 达到了1+1 > 2的效果, 明显提高了诊断的准确性[1-2]。随着PET-CT的广泛应用, 其对肿瘤定位定性诊断的优越性已得到临床医师的肯定, 本研究回顾性分析了70例经病理确诊的周围型肺癌病例的18F-FDGPET-CT结果。
18F-FDG PET-CT对周围型肺癌的诊断价值研究
The diagnostic value of PET-CT on peripheral lung cancer
-
摘要:
目的 探讨PET-CT对周围型肺癌的诊断价值。 方法 回顾性分析70例经病理证实的周围型肺癌患者的PET-CT影像资料,分析病灶的标准化摄取值(SUV)及其形态学表现。 结果 70例周围型肺癌患者中,鳞癌患者32例、腺癌患者25例、小细胞肺癌患者8例、腺鳞癌患者3例、大细胞肺癌2例。平均SUV=4.94±1.53,其中,66例患者的PET影像结果可见18F-FDG高浓聚,SUV≥2.5;另外4例的SUV < 2.5。SUV与肿块大小呈显著相关性。 结论 周围型肺癌大多具有较特殊的PET-CT影像学表现。PET-CT对周围型肺癌的诊断及鉴别诊断有较好的效能。SUV结合形态学分析有助于病灶的鉴别诊断。 -
关键词:
- 肺肿瘤 /
- 正电子发射断层显像术 /
- 体层摄影术, X线计算机 /
- 氟脱氧葡萄糖F18
Abstract:Objective To evaluate the value of PET-CT in the diagnosis of peripheral lung cancer. Methods The morphologic characteristics and standardized uptake value (SUV) of 70 patients with lung cancer proved by pathology were analyzed retrospectively. Results Of the 70 cases, 32 cases were squamous carcinoma, 25 cases were adenocarcinoma, 8 cases were small cell lung cancer, 3 cases were adenosquamous carcinoma and 2 cases were megacell lung cancer.The average SUV of the lung cancer was 4.94±1.53.In the group of lung cancer, hypermetabolic lesions were found in 66 cases and the SUV was more than 2.5 while the SUV was less than 2.5 in 4 cases.Positive correlation was showed in the SUV and the size of tumors. Conclusions The peripheral lung cancer has its special imaging appearances of PET-CT.PET-CT is an excellent modality in the diagnosis and differential diagnosis of peripheral lung cancer.The SUV combining with morphological findings sometimes may be helpful for the differential diagnosis. -
[1] 屈婉莹. 正电子发射计算机体层摄影-CT及其在肿瘤学中的临床应用. 中华放射学杂志, 2005, 39(11): 1127-1129.
[2] 屈婉莹, 郑建国, 林嘉滨. PET/CT临床应用优化选择的思考. 中华核医学杂志, 2006, 26(6): 327-329.
[3] Gaeta M, Barone M, Russi EG. et al. Carcinomatous solitary pulmonary nodules: evaluation of the tumor-bronchi relationship with thin-section CT. Radiology, 1993, 187(2): 535-539. [4] Shon IH, O'doherty MJ, Maisey MN, et al. Positron emission tomography in lung cancer. Semin Nucl Med, 2002, 32(4): 240-271. [5] Präuer HW, Weber WA. Römer W, et al. Controlled prospective study of positron emission tomography using the glucose analogue [18F] fluorodeoxyglucose in the evaluation of pulmonary nodules. Br J Surg, 1998, 85(11): 1506-1511. [6] Bousson V, Moretti JL, Weinmann P, et al. Assessment of malignancy in pulmonary lesions: FDG dual-head coincidence gamma camera imaging in association with serum tumor marker measurement. J Nucl Med, 2000, 41(11): 1801-1807. [7] Gould MK, Maclean CC, Kuschner WG, et al. Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis. JAMA, 2001, 285(7): 914-924.